The consequences of a U.S. retreat from the global response to HIV/AIDS would be immense, jeopardizing 40 years of progress.
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
Davenport-R Island-Moline KWQC on MSN5d
‘HIV is not a death sentence’: The Project of The Quad Cities helping erase the stigma around HIV/AIDSTPQC was formed at the height of the HIV-AIDS epidemic in 1986. Since then, their services have evolved and expanded with their original core mission still intact.
HIV, which causes AIDS, is now manageable, though there is still no cure. Now the Trump administration has put the brakes on foreign aid while alleging it’s wasteful, causing chaos in the system ...
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Human immunodeficiency virus (HIV) treatment has gotten so good that people can take a pill once a day to achieve viral ...
By paralyzing frontline response efforts led by community groups, the US decision to freeze funding is weakening health systems across the Global South. The freeze not only jeopardizes precious gains ...
HIV, which causes AIDS, is now manageable, though there is still no cure. Now the Trump administration has put the brakes on foreign aid while alleging it’s wasteful, causing chaos in the system ...
Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ...
Geneva, 13 February 2025 – On International Condom Day, UNAIDS and partners are calling for HIV prevention efforts to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback